Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Johnson and Johnson to open first Canadian JLABS incubator in Ontario
The facility, dubbed JLABS @ Toronto, is due to open in spring 2016. It will serve as a home for about 50 startups focused on biotechnology and pharmaceuticals,
The facility, dubbed JLABS @ Toronto, is due to open in spring 2016. It will serve as a home for about 50 startups focused on biotechnology and pharmaceuticals,
The update enables the company to use Daklinza in combination with sofosbuvir for 12 weeks in patients without cirrhosis in all 28 Member States of the European Union.
Vitaros, currently approved in the Europe and Canada, is a topical cream for the treatment of erectile dysfunction (ED). Under the deal, Apricus has exclusive rights to develop
The company will undertake the open-label Phase 2 trial in collaboration with MD Anderson Cancer Center in Houston. About 25 patients are expected to be enrolled in the
The trial will evaluate the safety of Eliquis in patients with nonvalvular atrial fibrillation (NVAF) with a recent acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI).
The randomized, double-blinded, dose-ranging, placebo-controlled Phase 2 trial will evaluate the safety and efficacy of a single, bilateral application of RT001 topical gel for the treatment of primary
US-based New Science Ventures led the financing round, which also included Belgian investors VIVES Louvain Technology Fund, NivelInvest, Fund+, Integrale, SRIW, SFPI-FPIM, Epimède and other individual participants. The
The company’s EySite-NanoM is a sustained-release delivery system designed to offer continuous release of its therapeutic anti-glaucoma agent for preventing the peak and trough drug levels that take
Daratumumab is an investigational, human anti-CD38 monoclonal antibody, which is designed to treat patients with relapsed and refractory multiple myeloma. Multiple myeloma is an incurable blood cancer that
Medidata Clinical Cloud platform will enhance data management capabilities and drive biomedical innovation in the development of a pneumococcal conjugate vaccine for infants. Walvax is using Medidata Rave